Breast CarcinomaCancerProcedure
What this study is
This study compares measurements of body composition to outcomes of breast reconstruction.
What's being tested
- Measurement of Body Composition
Intervention · PROCEDURE
Body composition measurements collected pre and post operatively using a bioelectrical impedance analyzer.
- Chart Review
Intervention · OTHER
Clinical and surgical data will be collected from the participants medical records.
Study details
- Official title
- Investigation Into the Utility of Novel Body Composition Measurements in Association With Outcomes of Breast Reconstruction
- Sponsor
- University of California, San Francisco
- Conditions
- Breast Carcinoma · Breast Cancer
- Enrolling
- 40 people
- Starts
- 2026-02-18
- Est. completion
- 2028-12-31
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Patients must have histologically confirmed breast malignancy or increased risk of developing a breast malignancy.
- Age ≥ 18 years.
- Scheduled to undergo mastectomy with immediate breast reconstruction using a permanent implant, tissue expander, or autologous tissue (e.g. Deep Inferior Epigastric Perforator (DIEP) flap, muscle-sparing Transverse Rectus Abdominis Myocutaneous (msTRAM) flap, Profunda Artery Perforator (PAP) flap).
- Ability to understand a written informed consent document, and the willingness to sign it.
You can't join if
- Any significant medical condition or laboratory abnormalities, which places the subject at unacceptable risk if he/she were to participate in the study.
- Pregnant or breastfeeding.
- Patients assigned male at birth.
- Non-cisgender women.
- Patients with implanted electronic medical devices (e.g. pacemaker, defibrillator).
- Patients with prosthetic limbs.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openUniversity of California
San Francisco, California, United States
- Michael Choi · Contact877-827-3222Michael.Choi@ucsf.edu
- Contact877-827-3222cancertrials@ucsf.edu
- Merisa Piper, MD · Principal investigator
Recruiting
Study team
Sponsor
University of California, San Francisco
Study ID 25759
Principal investigator
Merisas Piper, MD
University of California, San Francisco
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.